Published in J Cardiovasc Electrophysiol on November 01, 2006
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Cellular bases for human atrial fibrillation. Heart Rhythm (2008) 1.25
Cardiac adrenergic control and atrial fibrillation. Naunyn Schmiedebergs Arch Pharmacol (2009) 1.21
Post-operative atrial fibrillation: a maze of mechanisms. Europace (2011) 1.12
Selective molecular potassium channel blockade prevents atrial fibrillation. Circulation (2010) 1.11
Left versus right atrial difference in dominant frequency, K(+) channel transcripts, and fibrosis in patients developing atrial fibrillation after cardiac surgery. Heart Rhythm (2009) 1.00
Mechanisms of termination and prevention of atrial fibrillation by drug therapy. Pharmacol Ther (2011) 0.94
Effects of human atrial ionic remodelling by β-blocker therapy on mechanisms of atrial fibrillation: a computer simulation. Europace (2014) 0.81
Mechanisms of postcardiac surgery atrial fibrillation: more pieces in a difficult puzzle. Heart Rhythm (2009) 0.77
Probucol prevents atrial ion channel remodeling in an alloxan-induced diabetes rabbit model. Oncotarget (2016) 0.76
Up-regulation of miR-31 in human atrial fibrillation begets the arrhythmia by depleting dystrophin and neuronal nitric oxide synthase. Sci Transl Med (2016) 0.76
Comparison of the effects of bepridil and aprindine for the prevention of atrial fibrillation after cardiac and aortic surgery: A prospective randomized study. J Arrhythm (2015) 0.75
Preoperative atrial cardiomyocyte ionic currents and postoperative AF: important insights into what is not the mechanism. J Cardiovasc Electrophysiol (2006) 0.75
A multicenter risk index for atrial fibrillation after cardiac surgery. JAMA (2004) 5.20
Postoperative atrial fibrillation and mortality after coronary artery bypass surgery. J Am Coll Cardiol (2004) 3.49
Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res (1999) 3.22
Competing autonomic mechanisms precede the onset of postoperative atrial fibrillation. J Am Coll Cardiol (2003) 2.92
Molecular basis of functional voltage-gated K+ channel diversity in the mammalian myocardium. J Physiol (2000) 2.59
The contribution of ionic currents to changes in refractoriness of human atrial myocytes associated with chronic atrial fibrillation. Cardiovasc Res (2001) 2.41
Ascorbate attenuates atrial pacing-induced peroxynitrite formation and electrical remodeling and decreases the incidence of postoperative atrial fibrillation. Circ Res (2001) 2.25
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
Two types of transient outward currents in adult human atrial cells. Am J Physiol (1987) 1.73
An outwardly rectifying chloride channel in human atrial cardiomyocytes. J Cardiovasc Electrophysiol (2006) 1.52
Determinants and consequences of atrial fibrosis in patients undergoing open heart surgery. Cardiovasc Res (2002) 1.37
The gap-junctional protein connexin40 is elevated in patients susceptible to postoperative atrial fibrillation. Circulation (2001) 1.24
Transient outward and delayed rectifier currents in canine atrium: properties and role of isolation methods. Am J Physiol (1996) 1.22
Human inward rectifier potassium channels in chronic and postoperative atrial fibrillation. Cardiovasc Res (2002) 1.15
Predicting post-coronary bypass surgery atrial arrhythmias from the preoperative electrocardiogram. Am Heart J (2001) 1.07
Reversal of atrial electrical remodeling following cardioversion of long-standing atrial fibrillation in man. Cardiovasc Res (1999) 1.06
The ultrarapid and the transient outward K(+) current in human atrial fibrillation. Their possible role in postoperative atrial fibrillation. J Mol Cell Cardiol (2000) 1.01
Role of atrial ischaemia in development of atrial fibrillation following coronary artery bypass surgery. Eur J Cardiothorac Surg (1997) 1.01
Contribution of Na+/Ca2+ exchange to action potential of human atrial myocytes. Am J Physiol (1996) 0.97
Repetitive 4-week periods of atrial electrical remodeling promote stability of atrial fibrillation: time course of a second factor involved in the self-perpetuation of atrial fibrillation. Circulation (2004) 0.96
Age-related changes in human left and right atrial conduction. J Cardiovasc Electrophysiol (2006) 0.96
The use of atenolol in the prevention of supraventricular arrhythmias following coronary artery surgery. Eur Heart J (1988) 0.95
Off-pump coronary artery bypass graft surgery: the incidence of postoperative atrial fibrillation. Heart (2003) 0.94
Atrial fibrosis in heart surgery patients Decreased collagen III/I ratio in postoperative atrial fibrillation. Basic Res Cardiol (2005) 0.89
Heterogeneous changes in electrophysiologic properties in the paroxysmal and chronically fibrillating human atrium. J Cardiovasc Electrophysiol (1999) 0.85
Impairment of left atrial function predicts post-operative atrial fibrillation after coronary artery bypass graft surgery. Eur Heart J (2004) 0.85
Atrial fibrillation after cardiac surgery: update on the evidence on the available prophylactic interventions. Card Electrophysiol Rev (2003) 0.83
New insights into onset mechanisms of atrial fibrillation and flutter after coronary artery bypass graft surgery. Heart (2002) 0.83
Beta-blocker therapy in atrial fibrillation. Pacing Clin Electrophysiol (2003) 0.82
Preoperative use of sotalol versus atenolol for atrial fibrillation after cardiac surgery. Ann Thorac Surg (2004) 0.82
Increased dispersion of refractoriness in patients with atrial fibrillation in the early postoperative period after coronary artery bypass grafting. J Cardiovasc Electrophysiol (2003) 0.81
Sotalol reverses remodeled action potential in patients with chronic atrial fibrillation but does not prevent arrhythmia recurrence. J Cardiovasc Electrophysiol (2004) 0.79
Preoperative electrocardiographic risk assessment of atrial fibrillation after coronary artery bypass grafting. J Cardiovasc Electrophysiol (2004) 0.79
Vasoactive pressure hormones during and after cardiopulmonary bypass. Int J Artif Organs (1990) 0.79
Postoperative atrial fibrillation: some more answers, some new questions. J Cardiovasc Electrophysiol (2003) 0.78
Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial. Lancet (2002) 17.19
C-reactive protein is an independent predictor of risk for the development of diabetes in the West of Scotland Coronary Prevention Study. Diabetes (2002) 3.59
Progesterone for the prevention of preterm birth in twin pregnancy (STOPPIT): a randomised, double-blind, placebo-controlled study and meta-analysis. Lancet (2009) 2.28
A randomized trial comparing treatments for varicose veins. N Engl J Med (2014) 2.20
The short QT syndrome: proposed diagnostic criteria. J Am Coll Cardiol (2011) 1.99
Short- and long-term changes in plasma inflammatory markers associated with preeclampsia. Hypertension (2004) 1.92
Mortality in adults with newly diagnosed and chronic epilepsy: a retrospective comparative study. Lancet Neurol (2006) 1.83
Chronic beta-adrenoceptor blockade and human atrial cell electrophysiology: evidence of pharmacological remodelling. Cardiovasc Res (2003) 1.78
Observation or operation for patients with an asymptomatic inguinal hernia: a randomized clinical trial. Ann Surg (2006) 1.73
Atrial cellular electrophysiological changes in patients with ventricular dysfunction may predispose to AF. Heart Rhythm (2008) 1.72
Internal limiting membrane peeling versus no peeling for idiopathic full-thickness macular hole: a pragmatic randomized controlled trial. Invest Ophthalmol Vis Sci (2011) 1.66
Predictors of pharmacoresistant epilepsy. Epilepsy Res (2007) 1.65
Population-based trends in pregnancy hypertension and pre-eclampsia: an international comparative study. BMJ Open (2011) 1.64
Characterisation of the Na, K pump current in atrial cells from patients with and without chronic atrial fibrillation. Cardiovasc Res (2003) 1.62
Electrophysiological and arrhythmogenic effects of 5-hydroxytryptamine on human atrial cells are reduced in atrial fibrillation. J Mol Cell Cardiol (2006) 1.53
The safety and adequacy of antithrombotic therapy for atrial fibrillation: a regional cohort study. Br J Gen Pract (2006) 1.47
The effectiveness of cognitive behavior therapy for borderline personality disorder: results from the borderline personality disorder study of cognitive therapy (BOSCOT) trial. J Pers Disord (2006) 1.46
Greater response to cardiac resynchronization therapy in patients with true complete left bundle branch block: a PREDICT substudy. Europace (2011) 1.39
Longitudinal study of genital infection by herpes simplex virus type 1 in Western Scotland over 15 years. BMJ (2002) 1.37
Cellular bases for human atrial fibrillation. Heart Rhythm (2008) 1.25
The "PRIM" study: a randomized comparison of prostaglandin E2 gel with the nitric oxide donor isosorbide mononitrate for cervical ripening before the induction of labor at term. Am J Obstet Gynecol (2006) 1.11
Using patient-reported outcomes in schizophrenia: the Scottish Schizophrenia Outcomes Study. Psychiatr Serv (2009) 1.10
The role of covariates in estimating treatment effects and risk in long-term clinical trials. Stat Med (2002) 1.08
A pragmatic randomised, controlled trial of intensive care follow up programmes in improving longer-term outcomes from critical illness. The PRACTICAL study. BMC Health Serv Res (2007) 1.07
A Prospective Study of Pravastatin in the Elderly at Risk (PROSPER): Screening Experience and Baseline Characteristics. Curr Control Trials Cardiovasc Med (2002) 1.07
The cost-effectiveness of cognitive behavior therapy for borderline personality disorder: results from the BOSCOT trial. J Pers Disord (2006) 1.06
A randomized controlled trial of cognitive behavior therapy for borderline personality disorder: rationale for trial, method, and description of sample. J Pers Disord (2006) 1.04
Targeting sphingosine-1-phosphate signalling for cardioprotection. Curr Opin Pharmacol (2008) 1.04
Trial protocol OPPTIMUM-- does progesterone prophylaxis for the prevention of preterm labour improve outcome? BMC Pregnancy Childbirth (2012) 1.03
Anti-adrenergic effects of endothelin on human atrial action potentials are potentially anti-arrhythmic. J Mol Cell Cardiol (2006) 1.03
Carvedilol alone or in combination with digoxin for the management of atrial fibrillation in patients with heart failure? J Am Coll Cardiol (2003) 1.02
Are there socioeconomic differences in responses to a commonly used self report measure of chronic illness? Int J Epidemiol (2005) 1.02
The use of a novel nitinol guidewire to facilitate transseptal puncture and left atrial catheterization for catheter ablation procedures. Europace (2011) 0.98
Cognitive therapy v. usual treatment for borderline personality disorder: prospective 6-year follow-up. Br J Psychiatry (2010) 0.95
Exploring change processes in compassion focused therapy in psychosis: results of a feasibility randomized controlled trial. Br J Clin Psychol (2012) 0.94
Recruitment to publicly funded trials--are surgical trials really different? Contemp Clin Trials (2008) 0.94
Electrophysiological effects of 5-hydroxytryptamine on isolated human atrial myocytes, and the influence of chronic beta-adrenoceptor blockade. Br J Pharmacol (2003) 0.92
A mobile phone intervention to reduce binge drinking among disadvantaged men: study protocol for a randomised controlled cost-effectiveness trial. Trials (2014) 0.91
Mortality in epilepsy. Epilepsy Behav (2007) 0.90
Usefulness of fractional flow reserve to improve diagnostic efficiency in patients with non-ST elevation myocardial infarction. Am J Cardiol (2012) 0.90
A novel dietary intervention to optimize vitamin E intake of pregnant women to 15 mg/day. J Acad Nutr Diet (2012) 0.90
WISECARE+: Results of a European study of a nursing intervention for the management of chemotherapy-related symptoms. Eur J Oncol Nurs (2008) 0.87
The prevalence, nature, and importance of hematologic abnormalities in heart failure. Am Heart J (2006) 0.87
IMOP: randomised placebo controlled trial of outpatient cervical ripening with isosorbide mononitrate (IMN) prior to induction of labour - clinical trial with analyses of efficacy, cost effectiveness and acceptability. BMC Pregnancy Childbirth (2006) 0.86
Endothelin and the ischaemic heart. Curr Vasc Pharmacol (2005) 0.85
A web-based tool for teaching pharmacy practice competency. Am J Pharm Educ (2010) 0.85
Junctional rhythm--a suitable surrogate endpoint in catheter ablation of atrioventricular nodal reentry tachycardia? Pacing Clin Electrophysiol (2005) 0.85
Remodelling of human atrial K+ currents but not ion channel expression by chronic β-blockade. Pflugers Arch (2011) 0.82
The home as an appropriate setting for women undertaking cervical ripening before the induction of labour. Midwifery (2010) 0.82
A pragmatic multi-centre randomised controlled trial of fluid loading in high-risk surgical patients undergoing major elective surgery--the FOCCUS study. Crit Care (2011) 0.82
Apex-to-base dispersion of refractoriness underlies the proarrhythmic effect of hypokalaemia/hypomagnesaemia in the rabbit heart. J Electrocardiol (2002) 0.81
Adrenomedullin acts via nitric oxide and peroxynitrite to protect against myocardial ischaemia-induced arrhythmias in anaesthetized rats. Br J Pharmacol (2006) 0.81
A feasibility randomised controlled trial of the New Orleans intervention for infant mental health: a study protocol. ScientificWorldJournal (2013) 0.81
Acute administration of cannabidiol in vivo suppresses ischaemia-induced cardiac arrhythmias and reduces infarct size when given at reperfusion. Br J Pharmacol (2010) 0.80
IP(3)R-mediated Ca(2+) release is modulated by anandamide in isolated cardiac nuclei. J Mol Cell Cardiol (2008) 0.80
Ximelagatran compared with warfarin for the prevention of systemic embolism and stroke. An imputed placebo analysis. Cardiovasc Drugs Ther (2005) 0.80
Electrophysiological effects of prucalopride, a novel enterokinetic agent, on isolated atrial myocytes from patients treated with beta-adrenoceptor antagonists. J Pharmacol Exp Ther (2005) 0.80
Prevalence of cardiac sarcoidosis in patients presenting with monomorphic ventricular tachycardia. Pacing Clin Electrophysiol (2013) 0.80
Duration of heart failure and the risk of atrial fibrillation: different mechanisms at different times? Cardiovasc Res (2009) 0.79
Impact and influences on caregiver outcomes at one year post-stroke. Cerebrovasc Dis (2004) 0.79
Power and sample size for cost-effectiveness analysis: fFN neonatal screening. Contemp Clin Trials (2011) 0.78
Sarafotoxin 6c (S6c) reduces infarct size and preserves mRNA for the ETB receptor in the ischemic/reperfused myocardium of anesthetized rats. J Cardiovasc Pharmacol (2004) 0.77
Designing and implementing E-health Applications in the UK's National Health Service. J Health Commun (2005) 0.77
Risky single-occasion drinking and disadvantaged men: will recruitment through primary care miss hazardous drinkers? Alcohol Clin Exp Res (2013) 0.76
Study of progesterone for the prevention of preterm birth in twins (STOPPIT): findings from a trial-based cost-effectiveness analysis. Int J Technol Assess Health Care (2010) 0.76
Radiation safety and ergonomics in the electrophysiology laboratory: update on recent advances. Curr Opin Cardiol (2016) 0.76
Activation of protease activated receptor-2 induces delayed cardioprotection in anesthetized mice. Cardiovasc Drugs Ther (2009) 0.76
Ventricular arrhythmias in patients with heart failure secondary to reduced ejection fraction: a current perspective. Curr Opin Cardiol (2014) 0.76
Looking for prognostic information in the ST-T segment--is it really worth it? J Electrocardiol (2004) 0.75
Electrophysiological and haemodynamic effects of endothelin ETA and ETB receptors in normal and ischaemic working rabbit hearts. Br J Pharmacol (2005) 0.75
RApid Primary care Initiation of Drug treatment for Transient Ischaemic Attack (RAPID-TIA): study protocol for a pilot randomised controlled trial. Trials (2013) 0.75
Assessing catheter-associated urinary tract infection - Authors' reply. Lancet (2013) 0.75
Do hypoxemia or hypercapnia predispose to atrial fibrillation in breathing disorders, and, if so, how? Heart Rhythm (2010) 0.75